Annis Allen Insider Trades

Insider Trading History

Track insider trading activity for Annis Allen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aileron Therapeutics
Aileron Therapeutics ALRN
Svp, Research
Holding Value $660k 313,000 shares
Last Trade
Mar 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3M 313,000 shares
$9.60
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
Svp, Research
Holding Value $660k 313,000 shares
Last Trade
Mar 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.75M 313,000 shares
$8.80
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
Svp, Research
Holding Value $1M 474,000 shares
Last Trade
Jun 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2M 474,000 shares
$25.80
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
Svp, Research
Holding Value $264k 125,000 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.7M 125,000 shares
$13.56
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
Svp, Research
Holding Value $211k 100,000 shares
Last Trade
Apr 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.5M 100,000 shares
$35.00
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
See Remarks
Holding Value $15.9k 7,547 shares
Last Trade
Nov 03, 2018 Sale
$2.98M 69,293 shares
$43.00
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
10% owner
Holding Value $0 0 shares
Last Trade
Jun 28, 2017 Sale
No data
No data
$2.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up